Fegley D, Kathuria S, Mercier R, Li C, Goutopoulos A, Makriyannis A, Piomelli D (2004) Anandamide transport is independent of fatty-acid
amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci USA 101:8756 – 8761.
Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids
in synaptic signaling. Physiol Rev 83:1017–1066.
Fukudome Y, Ohno-Shosaku T, Matsui M, Omori Y, Fukaya M, Tsubokawa
H, Taketo MM, Watanabe M, Manabe T, Kano M (2004) Two distinct
classes of muscarinic action on hippocampal inhibitory synapses: M2- mediated direct suppression and M1/M3-mediated indirect suppression
through endocannabinoid signalling. Eur J Neurosci 19:2682–2692.
Gerdeman GL, Lovinger DM (2003) Emerging roles for endocannabinoids
in long-term synaptic plasticity. Br J Pharmacol 140:781–789.
Gerdeman GL, Ronesi J, Lovinger DM (2002) Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 5:446 – 451.
Ha ́ jos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, Freund TF
(2000) Cannabinoids inhibit hippocampal GABAergic transmission and
network oscillations. Eur J Neurosci 12:3239 –3249.
Ha ́ jos N, Ledent C, Freund TF (2001) Novel cannabinoid-sensitive receptor
mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106:1– 4.
Hashimotodani Y, Ohno-Shosaku T, Tsubokawa H, Ogata H, Emoto K, Maejima T, Araishi K, Shin HS, Kano M (2005) Phospholipase Cbeta serves
as a coincidence detector through its Ca 2 dependency for triggering
retrograde endocannabinoid signal. Neuron 45:257–268.
Hillard CJ, Edgemond WS, Jarrahian A, Campbell WB (1997) Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J Neurochem 69:631– 638.
Hoffman AF, Riegel AC, Lupica CR (2003) Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct
neuron populations of the hippocampus. Eur J Neurosci 18:524 –534.
Hoffman AF, Macgill AM, Smith D, Oz M, Lupica CR (2005) Species and
strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus. Eur J Neurosci
22:2387–2391.
Jung KM, Mangieri R, Stapleton C, Kim J, Fegley D, Wallace M, Mackie K,
Piomelli D (2005) Stimulation of endocannabinoid formation in brain
slice cultures through activation of group I metabotropic glutamate re- ceptors. Mol Pharmacol 68:1196 –1202.
Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF (1999)
Presynaptically located CB1 cannabinoid receptors regulate GABA release
from axon terminals of specific hippocampal interneurons. J Neurosci
19:4544 – 4558.
Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E, Watanabe M,
Ohno-Shosaku T, Kano M (2006) The CB1 cannabinoid receptor is the
major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 26:2991–3001.
Kim J, Alger BE (2004) Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci
7:697– 698.
Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA,
Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M
(1999) Unresponsiveness to cannabinoids and reduced addictive effects
of opiates in CB1 receptor knockout mice. Science 283:401– 404.
Lujan R, Nusser Z, Roberts JD, Shigemoto R, Somogyi P (1996) Perisynaptic
location of metabotropic glutamate receptors mGluR1 and mGluR5 on
dendrites and dendritic spines in the rat hippocampus. Eur J Neurosci
8:1488 –1500.
Lujan R, Roberts JD, Shigemoto R, Ohishi H, Somogyi P (1997) Differential
plasma membrane distribution of metabotropic glutamate receptors
mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter re- lease sites. J Chem Neuroanat 13:219 –241.
Makara JK, Mor M, Fegley D, Szabo SI, Kathuria S, Astarita G, Duranti A,
Tontini A, Tarzia G, Rivara S, Freund TF, Piomelli D (2005) Selective
